Fortrea
Peggy Pereda currently serves as the Executive Director of Medical Device and Diagnostic Development at Fortrea, a position held since May 2023. Prior to this role, Peggy held similar executive positions at Labcorp and Covance, focusing on Medical Device and Diagnostic Solutions. Peggy's experience additionally includes a significant tenure at RCRI, Inc., where responsibilities encompassed clinical research and senior advisory roles, along with leadership positions in biostatistics and information management. Earlier career highlights include director-level roles at Boston Scientific and a foundational role as a statistical consultant at Abbott Laboratories. Peggy holds a Master of Science in Statistics from North Carolina State University and a Bachelor of Arts in Statistics and Mathematics from St. Cloud State University.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.